Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Gene therapies correct three forms of retinal degenerative diseases

Gene therapies developed by University of Pennsylvania School of Veterinary Medicine researchers have worked to correct different forms of blindness. While effective, the downside to these approaches to vision rescue is that each disease requires its own form of gene therapy to correct the particular genetic mutation involved, a time consuming and complex process.

17 Jan 2014

Gouty tophi predict cardiovascular remodeling

Research shows that the severity of gout, rather than uric acid level, is significantly associated with changes in left ventricular diastolic function and left atrial volume.

16 Jan 2014

Researchers develop "smart" hydrogel that can deliver medicine on demand

Researchers at the University of Delaware have developed a "smart" hydrogel that can deliver medicine on demand, in response to mechanical force.

16 Jan 2014

Obesity interferes with blood pressure control

Patients who are overweight or obese have a high risk for uncontrolled blood pressure, despite often taking multiple antihypertensive agents, say researchers.

13 Jan 2014

Cardiovascular conditions may be overlooked in bipolar disorder

Cardiovascular comorbidities may be going under-recognized and undertreated in patients with bipolar disorder, say UK researchers.

10 Jan 2014

NPF, CORRONA to create first psoriasis registry to improve treatments and patient outcomes

To advance understanding of psoriasis—the most common autoimmune disease in the country, affecting up to 7.5 million Americans—and help scientists and clinicians improve treatments and patient outcomes, the National Psoriasis Foundation and the Consortium of Rheumatology Researchers of North America, Inc. will create the first psoriasis registry co-developed and co-administered by a nonprofit.

10 Jan 2014

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema - a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults.

10 Jan 2014

TSRI scientists identify small subset of immune cells that play major role in development of Crohn's disease

Two-thirds to three-quarters of the estimated 700,000 Americans living with Crohn's disease, an autoimmune condition that can disrupt the entire gastrointestinal tract, will require surgery at some point during their life.

9 Jan 2014

Study finds discrepancies in prevalence estimates of mental disorders in middle-aged and older adults

Common methods of assessing mental or physical disorders may consistently underestimate the prevalence of mental disorders among middle-aged and older adults, a new study from the Johns Hopkins Bloomberg School of Public Health has found.

9 Jan 2014

Nociceptin in brain naturally moderates effects of stress

Collaborating scientists at The Scripps Research Institute (TSRI), the National Institutes of Health (NIH) and the University of Camerino in Italy have published new findings on a system in the brain that naturally moderates the effects of stress.

8 Jan 2014

Plasma thermogram can serve as an indicator of cervical cancer

Researchers at the University of Louisville have confirmed that using the heat profile from a person's blood, called a plasma thermogram, can serve as an indicator for the presence or absence of cervical cancer, including the stage of cancer.

8 Jan 2014

Lower bone strength may predispose children to factures resulting from weakened later in life

Broken bones may seem like a normal part of an active childhood. About 1 in 3 otherwise healthy children suffers a bone fracture. Breakage of the bone running from the elbow to the thumb side of the wrist (distal forearm fracture) is the most common.

8 Jan 2014

Synthetic cannabinoid molecule created for osteoarthritis

Chemical compounds synthesised in the laboratory, similar to those found in cannabis, could be developed as potential drugs to reduce the pain of osteoarthritis.

7 Jan 2014

Longer duration breastfeeding may reduce risk of rheumatoid arthritis

In a new study of over 7,000 older Chinese women published online today in the journal Rheumatology, breastfeeding - especially for a longer duration - is shown to be associated with a lower risk of rheumatoid arthritis.

6 Jan 2014

Tight blood pressure control urged in patients with cardiovascular disease

Intensive antihypertensive treatment to a systolic blood pressure target of 130 mmHg is equally beneficial for patients with and without established cardiovascular disease, research suggests.

6 Jan 2014

Children are likely to have stronger muscles if mothers had higher level of vitamin D during pregnancy

Children are likely to have stronger muscles if their mothers had a higher level of vitamin D in their body during pregnancy, according to new research from the Medical Research Council Lifecourse Epidemiology Unit (MRC LEU) at the University of Southampton.

3 Jan 2014

Biologists discover effective strategy that could prevent immune system from rejecting grafts

Biologists at UC San Diego have discovered an effective strategy that could prevent the human immune system from rejecting the grafts derived from human embryonic stem cells, a major problem now limiting the development of human stem cell therapies.

3 Jan 2014

Surgeon highlights factors that can prevent revision surgery after hip or knee replacement

Hundreds of thousands of hip and knee replacement surgeries are performed in the United States each year, and they are highly successful in eliminating pain, restoring mobility and improving quality of life.

2 Jan 2014

Penn researchers receive PCORI awards to develop, expand health data network for patients, researchers

Two teams led by researchers in the Perelman School of Medicine at the University of Pennsylvania have been approved for funding awards by the Patient-Centered Outcomes Research Institute (PCORI).

31 Dec 2013

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.

30 Dec 2013

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Gene therapies correct three forms of retinal degenerative diseases

Gouty tophi predict cardiovascular remodeling

Researchers develop "smart" hydrogel that can deliver medicine on demand

Obesity interferes with blood pressure control

Cardiovascular conditions may be overlooked in bipolar disorder

NPF, CORRONA to create first psoriasis registry to improve treatments and patient outcomes

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

TSRI scientists identify small subset of immune cells that play major role in development of Crohn's disease

Study finds discrepancies in prevalence estimates of mental disorders in middle-aged and older adults

Nociceptin in brain naturally moderates effects of stress

Plasma thermogram can serve as an indicator of cervical cancer

Lower bone strength may predispose children to factures resulting from weakened later in life

Synthetic cannabinoid molecule created for osteoarthritis

Longer duration breastfeeding may reduce risk of rheumatoid arthritis

Tight blood pressure control urged in patients with cardiovascular disease

Children are likely to have stronger muscles if mothers had higher level of vitamin D during pregnancy

Biologists discover effective strategy that could prevent immune system from rejecting grafts

Surgeon highlights factors that can prevent revision surgery after hip or knee replacement

Penn researchers receive PCORI awards to develop, expand health data network for patients, researchers

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Forensics and toxicology - Industry Focus eBook eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Forensics and toxicology - Industry Focus eBook eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Newsletters you may be interested in